Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;74(1):529.
doi: 10.1002/hep.31668.

Letter to the Editor: ABIDE Model for Predicting Decompensation in Nonalcoholic Fatty Liver Disease-Related Cirrhosis

Abhinav Anand  1 , Piyush Pathak  1 , Shalimar  1
Affiliations
Comment

Letter to the Editor: ABIDE Model for Predicting Decompensation in Nonalcoholic Fatty Liver Disease-Related Cirrhosis

Abhinav Anand et al. Hepatology. 2021 Jul.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Calzadilla-Bertot L, Vilar-Gomez E, Wong VS, Romero-Gomez M, Aller-de la Fuente R, Wong GH, et al. ABIDE: An accurate predictive model of liver decompensation in patients with non-alcoholic fatty liver-related cirrhosis. Hepatology 2020 Sep 25. https://doi.org/10.1002/hep.31576. [Epub ahead of print]
    1. Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: A multi-national cohort study. Gastroenterology 2018;155:443-457.e17.
    1. Papastergiou V, Tsochatzis E, Burroughs AK. Non-invasive assessment of liver fibrosis. Ann Gastroenterol 2012;25:218-231.
    1. Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J, et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69:406-460.
    1. Glass LM, Dickson RC, Anderson JC, Suriawinata AA, Putra J, Berk BS, et al. Total body weight loss of ≥10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis. Dig Dis Sci 2015;60:1024-1030.